Source: Abstracts. Conference titles: Annual Meeting of Association for Research in Vision and Ophthalmology (ARVO). Unidade: FMRP
Subjects: IMPLANTE DE LENTE INTRAOCULAR, SEDATIVOS (EFEITOS ADVERSOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, M. M. et al. In vivo release and retinal safety of intravitreal implants of thalidomide in rabbit eyes and antiangiogenic effect on the chorioallantoic membrane. 2013, Anais.. Seattle: ARVO, 2013. . Acesso em: 07 nov. 2024.APA
Oliveira, M. M., Fialho, S., Souza, M., Souza, P., Fulgêncio, G., Haddad, A., et al. (2013). In vivo release and retinal safety of intravitreal implants of thalidomide in rabbit eyes and antiangiogenic effect on the chorioallantoic membrane. In Abstracts. Seattle: ARVO.NLM
Oliveira MM, Fialho S, Souza M, Souza P, Fulgêncio G, Haddad A, Cunha AS, Messias AMV, Jorge R. In vivo release and retinal safety of intravitreal implants of thalidomide in rabbit eyes and antiangiogenic effect on the chorioallantoic membrane. Abstracts. 2013 ;[citado 2024 nov. 07 ]Vancouver
Oliveira MM, Fialho S, Souza M, Souza P, Fulgêncio G, Haddad A, Cunha AS, Messias AMV, Jorge R. In vivo release and retinal safety of intravitreal implants of thalidomide in rabbit eyes and antiangiogenic effect on the chorioallantoic membrane. Abstracts. 2013 ;[citado 2024 nov. 07 ]
